Skip to main content

Table 8 Summary of the median (min, max) values for each treatment group at screening (D-7) and end of study (D28) for selected hematology parameters

From: A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain

 

NV-01 D-7

NV-01 D28

Placebo D-7

Placebo D28

WBC (x10 3 /UL)

8.47 (5.34,11.62)

9.27 (5.41,13.22)

9.57 (5.85,14.48)

9.91 (5.72,14.47)

RBC (x10 6 /UL)

6.39 (5.38,7.39)

6.06 (5.14,7.25)

6.99 (5.95,8.1)

6.78 (5.69,8.27)

HGB (G/DL)

15 (13.1,18.7)

14.65 (11.9,16.7)

16.4 (14.2,18.1)

16.3 (14,19)

HCT (%)

44.4 (36.8,55.1)

42.3 (34.8,47.4)

47.2 (42.2,52.2)

47.3 (39.4,53.8)

PCV (%)

45 (37,53)

41.5 (35,48)

47 (43,53)

47 (40,53)

  1. WBC = White blood cell count; RBC = red blood cell count; HGB = hemoglobin; HCT = hematocrit; PCV = packed cell volume.